MedTrace Logo

What Impact Does an Initial Psycho-oncological Contact Have on People With Cancer?

NCT07544446 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2026-04-22

No results posted yet for this study

Summary

When diagnosed with cancer, patients or their relatives may, if they wish, on the recommendation of the treatment team and/or in cases of high stress, seek psycho-oncological support.

This study investigates whether an initial consultation with a psycho-oncological specialist reduces anxiety and depression, improves quality of life, and whether patients subsequently make greater use of support services.

Participants will be randomised, meaning they will be assigned to groups at random to ensure that the results are comparable. In the intervention group, participants will receive a detailed initial consultation with a psycho-oncology specialist and standard treatment. In the control group, participants receive standard treatment. To gather results, questionnaires are administered at regular intervals (at the start, after 3 and 6 months). The study lasts a total of 6 months.

The study was developed by patients. It is being conducted simultaneously at several hospitals.

Conditions

Interventions

OTHER

initial psycho-oncological contact

initial psycho-oncological contact and a 3 months follow-up contact

OTHER

Standard

actual standard of care psycho-oncological support according to local processes

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER

  • St. Claraspital AG

    collaborator OTHER

  • Klinik Hirslanden, Zurich

    collaborator OTHER

  • Lindenhofgruppe AG

    lead INDUSTRY

Principal Investigators

  • Janine Antonov, PhD, eMBA · Forschungszentrum Lindenhofgruppe

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07544446 on ClinicalTrials.gov